FDA Inspection
Department AF 81st Med. Group/SGQC Keesler AFB MC Blood BankDepartment AF 81st Med. Group/SGQC Keesler AFB MC Blood Bank – FDA Inspection, Aug 8, 2017
Record Details
This FDA Inspection record concerns Department AF 81st Med. Group/SGQC Keesler AFB MC Blood Bank, with an inspection on August 8, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- August 8, 2017
- Product Type
- Biologics
View Company Profile
ID · 79b6f259-68b9-44dd-be52-f4523a6b15a3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1021631
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 630.10(h)Ineligible Donor
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Department AF 81st Med. Group/SGQC Keesler AFB MC Blood Bank
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 6, 2024 | Not classified | New Orleans District Office | |
| March 6, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 23, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 22, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Department AF 81st Med. Group/SGQC Keesler AFB MC Blood Bank
- FDA Inspection 1251708 - 2024-09-06
- FDA Inspection 916765 - 2015-03-06
- FDA Inspection 815251 - 2013-01-23
- FDA Inspection 683172 - 2010-09-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.